Carregant...
Converting cancer mutations into therapeutic opportunities
While the use of synthetic lethality has been around for decades in model organism studies, it has only recently been applied to cancer therapy and judging by recent results, with great success. Following on a recent paper that demonstrates the clinical application of this strategy (Fong et al, 2009...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
WILEY-VCH Verlag
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3378146/ https://ncbi.nlm.nih.gov/pubmed/20049732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.200900044 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|